19-Apr-2024
Globe Newswire (Wed, 17-Apr 9:23 AM ET)
Analysts Offer Insights on Healthcare Companies: Edgewise Therapeutics (EWTX) and Progyny (PGNY)
TipRanks (Wed, 17-Apr 7:41 AM ET)
Progyny and RESOLVE to Honor National Infertility Awareness Week with Events Spanning Coast to Coast
Globe Newswire (Thu, 4-Apr 8:59 AM ET)
Progyny, Inc. to Present at KeyBanc Life Sciences & MedTech Investor Forum
Globe Newswire (Mon, 18-Mar 12:00 PM ET)
Progyny, Inc. to Present at Barclays 26th Annual Global Healthcare Conference
Globe Newswire (Mon, 11-Mar 12:00 PM ET)
Progyny, Inc. Announces Share Repurchase Program
Globe Newswire (Thu, 29-Feb 7:30 AM ET)
Progyny, Inc. Announces Fourth Quarter 2023 Results
Globe Newswire (Tue, 27-Feb 4:01 PM ET)
Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2023 Results Report
Globe Newswire (Tue, 13-Feb 4:30 PM ET)
Progyny Inc is a company engaged in specializing in fertility and family building benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of the treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments and active management of the selective network of high-quality provider clinics.
Progyny trades on the NASDAQ stock market under the symbol PGNY.
As of April 19, 2024, PGNY stock price climbed to $32.70 with 1,063,044 million shares trading.
PGNY has a beta of 1.03, meaning it tends to be more sensitive to market movements. PGNY has a correlation of 0.12 to the broad based SPY ETF.
PGNY has a market cap of $3.14 billion. This is considered a Mid Cap stock.
Last quarter Progyny reported $270 million in Revenue and $.13 earnings per share. This fell short of revenue expectation by $-4 million and exceeded earnings estimates by $.03.
In the last 3 years, PGNY stock traded as high as $68.32 and as low as $25.67.
The top ETF exchange traded funds that PGNY belongs to (by Net Assets): VTI, IJH, VB, IWM, VXF.
PGNY has underperformed the market in the last year with a price return of +0.4% while the SPY ETF gained +21.2%. PGNY has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -14.4% and -7.9%, respectively, while the SPY returned +4.3% and -3.5%, respectively.
PGNY support price is $31.27 and resistance is $32.49 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PGNY stock will trade within this expected range on the day.